[Viminol in the treatment of pain. Double-blind, controlled, multicentric trial].
D000632:Aminopyrine / Q000627:therapeutic use; D000700:Analgesics / Q000009:adverse effects / Q000627:therapeutic use*; D001241:Aspirin / Q000627:therapeutic use; D001565:Benzoates / Q000009:adverse effects; D001593:Benzyl Compounds / Q000627:therapeutic use; D011431:Dextropropoxyphene / Q000627:therapeutic use; D004341:Drug Evaluation; D004361:Drug Tolerance; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D009020:Morphine / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced; D010146:Pain / Q000188:drug therapy*; D010423:Pentazocine / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use; D012893:Sleep Wake Disorders / Q000139:chemically induced; D014717:Vertigo / Q000139:chemically induced
D000700:Analgesics; D001565:Benzoates; D001593:Benzyl Compounds; D004983:Ethanolamines; D011758:Pyrroles; D000632:Aminopyrine; D009020:Morphine; D010653:Phenylbutazone; D001241:Aspirin; D010423:Pentazocine; D011431:Dextropropoxyphene
Il viminolo nel trattamento del dolore. Ricerca controllata doppio-cieca di tipo multicentrico.